Technology Profiles
by Date
by Sector
Search

Expression of Interest

27.09.2010: First causal treatment option for Friedreich's Ataxia via Erythropoietin (EPO) - 10 AT 0102 3I40

Which information is missing or unclear?
What kind of co-operation are you looking for?
Some facts about your company:
 
Choose an office location nearest to you:
Country:
 
Your contact data:
Name:  
Company:  
Country:  
Town:  
Phone:  
e-Mail:  
 
back to profile
 
Profiles of high Interest
- Antigens for diagnostics of Q fever and other rickettsial infections, 232 views
- Freeze Granulation - Homogeneous granules for processing of ceramic, diamond, nano and/or composite materials, 95 views